サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1490273

個別化精神医学市場：製品タイプ別、治療分野別、エンドユーザー別、技術別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Personalized Psychiatry Market, By Product Type, By Therapeutic Areas, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
個別化精神医学市場：製品タイプ別、治療分野別、エンドユーザー別、技術別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

個別化精神医学市場規模は2023年に42億943万米ドルとなり、2024年から2032年にかけてCAGR 11.98％で拡大

個別化精神医学市場-市場力学

精神疾患の有病率の上昇

精神疾患の罹患率の増加は、個別化精神医学市場を大きく推進しています。患者一人ひとりの特性に合わせて治療計画を調整する個別化精神医療は、メンタルヘルス疾患の複雑で多様な性質への対応として支持を集めています。うつ病、不安神経症、双極性障害、統合失調症などのメンタルヘルス疾患と診断される患者数の増加が、主な促進要因となっています。世界保健機関（WHO）の報告によると、うつ病は世界中で障害の主な原因となっており、2億6,400万人以上が罹患しています。メンタルヘルスの問題に対する認識の高まりと、助けを求めることの非人格化が、診断率の向上に寄与しています。デジタルヘルスプラットフォームとモバイルヘルスアプリケーションの台頭は、継続的なモニタリングとリアルタイムのデータ収集を提供することで、個別化ケアを促進しています。

個別化精神医学市場-主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約11.98%のCAGRで毎年成長すると推定されます。

製品タイプ別では、ゲノミクスが2023年に最大の市場シェアを示すと予測されています。

治療領域のセグメンテーションに基づくと、2023年にはうつ病と不安症が主要タイプでした。

エンドユーザーセグメンテーションに基づくと、2023年にはヘルスケアプロバイダーが主要タイプでした。

地域別では、北米が2023年の主要収益源であった

個別化精神医学市場-セグメンテーション分析：

世界の個別化精神医学市場は、製品タイプ、治療分野、エンドユーザー、技術、地域に基づいて区分されます。

市場は製品タイプにより3つに分類される：ゲノミクス、デジタル治療薬、ソフトウェアです。ヘルスケア分野でのデジタル機器利用の増加により、2023年にはゲノミクスカテゴリーが最大の市場シェアを占め、デジタル治療学セグメントは今後数年間で最も速い速度で発展すると予測されます。ゲノム技術の発展により、精神疾患と関連する遺伝的差異を特定することが可能になり、カスタマイズされた治療計画への扉が開かれました。

市場は治療領域に基づいて5つのカテゴリーに分類される：うつ病、不安障害、双極性障害、中毒、その他です。2023年には、うつ病と不安障害の市場はかなりの規模に達すると予想され、その後数年間はさらに急成長することが予想されます。さまざまな病気の間でばらつきがあり、人によって根本的な原因や治療結果が異なることへの理解が広がっています。この理解により、診断と治療の個別化手法に対するニーズが高まっています。

個別化精神医学市場-地理的洞察

個別化された精神医学的介入の必要性は、北米における精神衛生問題の有病率の増加によって高まっています。さらに、この地域には優れた調査とヘルスケアのインフラがあり、個別化医療戦略の構築と導入を支えています。さらに、ヘルスケア革新への強力な投資と政府による規制やイニシアチブが、北米における個別化精神医療市場の拡大を後押ししています。個別化精神医療市場は、アジア太平洋地域で最も速い速度で成長すると予想されています。この成長は、ヘルスケア技術への投資拡大、メンタルヘルス問題への認識向上、ヘルスケアインフラの整備などの要素によってもたらされます。

個別化精神医学市場-競合情勢：

大手製薬会社は個別化精神医学への投資を増やしています。大手製薬会社は、遺伝子やバイオマーカーの情報に基づいて、オーダーメイドの薬を開発しています。ジョンソン・エンド・ジョンソン、ファイザー、ロシュのような企業がこの分野では著名です。バイオテクノロジー企業は、革新的な診断ツールや治療法を開発する最前線にいます。ニッチな分野に焦点を当て、最先端技術を活用することが多いです。例えば、Myriad Genetics、Genomind、Assurex Healthなどです。製薬会社、バイオテクノロジー企業、学術機関、テクノロジー・プロバイダー間の共同研究の動向も活発化しています。こうしたパートナーシップは、研究を推進し、新たな個別化治療を市場に投入するために不可欠です。例えば、2024年5月、精神医学のハンドリングと調査プラットフォームの第一人者であるOsmind社は、精神医学における精密治療と同様に、測定に基づくケア（MBC）の実施を推進するため、米国精神医学会（APA）との画期的なパートナーシップを発表しました。

目次

第1章 個別化精神医学市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 個別化精神医学の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 個別化精神医学産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 個別化精神医学市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 個別化精神医学市場情勢

  • 個別化精神医学市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 個別化精神医学市場 - 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ゲノミクス
    • デジタルセラピューティクス
    • ソフトウェア

第8章 個別化精神医学市場 - 治療分野別

  • 概要
    • 治療領域別セグメントシェア分析
    • うつ病と不安
    • 双極性障害
    • 中毒
    • その他

第9章 個別化精神医学市場 - エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • メンタルヘルス専門家
    • 患者
    • ヘルスケア提供者

第10章 個別化精神医学市場 - 技術別

  • 概要
    • 技術別セグメントシェア分析
    • シーケンシング
    • ポリメラーゼ連鎖反応
    • マイクロアレイ
    • 免疫測定
    • その他

第11章 個別化精神医学市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 個別化精神医学業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GreyBird Ventures
    • Sunovion Pharmaceuticals Inc.
    • HMNC Holding GmbH
    • Arcara Personalized Psychiatry
    • Starling Minds
    • Karuna Therapeutics
    • CBT Plus
    • AltheaDx, Inc.
    • WayForward
    • BrightQuest
    • Peak Mental Wellness
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Psychiatry Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Personalized Psychiatry Market, by Product Type 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Therapeutic Areas Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Personalized Psychiatry Market, by Therapeutic Areas 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Personalized Psychiatry Market, by End User 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Personalized Psychiatry Market, by Technology 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Psychiatry Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
目次
Product Code: ANV2847

REPORT HIGHLIGHT

Personalized Psychiatry Market size was valued at USD 4,209.43 million in 2023, expanding at a CAGR of 11.98% from 2024 to 2032.

The growing incidence of conditions like depression, anxiety, bipolar disorder, and schizophrenia necessitates more effective and personalized treatment methods. Increasing understanding of the genetic basis of psychiatric disorders is enabling more personalized treatment approaches. The development and implementation of personalized treatment plans can be expensive, limiting accessibility for some patients. International efforts to address the global mental health crisis can support the development and dissemination of personalized psychiatry approaches.

Personalized Psychiatry Market- Market Dynamics

Rising Prevalence of Mental Health Disorders

The growing incidence of mental health disorders is significantly propelling the personalized psychiatry market. Personalized psychiatry, which tailors treatment plans to the individual characteristics of each patient, is gaining traction as a response to the complex and varied nature of mental health conditions. The rising number of individuals diagnosed with mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia is a primary driver. The World Health Organization (WHO) reports that depression is a leading cause of disability worldwide, affecting over 264 million people. The growing recognition of mental health issues and the destigmatization of seeking help are contributing to higher diagnosis rates. The rise of digital health platforms and mobile health applications is facilitating personalized care by providing continuous monitoring and real-time data collection.

Personalized Psychiatry Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.98% over the forecast period (2024-2032)

Based on product type segmentation, Genomics was predicted to show maximum market share in the year 2023

Based on therapeutic areas segmentation, Depression and Anxiety was the leading type in 2023

Based on end users segmentation, Healthcare Providers was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Personalized Psychiatry Market- Segmentation Analysis:

The Global Personalized Psychiatry Market is segmented based on Product Type, therapeutic areas, End-user, Technology, and Region.

The market is divided into three categories based on product type: Genomics, Digital Therapeutics, and Software. Due to the rise in the use of digital devices in the healthcare sector, the genomics category holds the largest market share in 2023, while the digital therapeutics segment is predicted to develop at the quickest rate in the upcoming years. Thanks to developments in genomic technologies, it is now possible to identify genetic differences linked to psychiatric diseases, which opens the door to customized treatment plans.

The market is divided into five categories based on therapeutic areas: Depression, Anxiety, Bipolar Disorders, Addiction, and Others. In 2023, the market for depression and anxiety is expected to reach a sizeable amount, and in the ensuing years, it is expected to grow even faster. the expanding understanding of the variability among various illnesses, with different underlying causes and treatment outcomes for different people. This understanding has increased the need for individualized methods of diagnosis and therapy.

Personalized Psychiatry Market- Geographical Insights

The need for individualized psychiatric interventions is being driven by the increasing prevalence of mental health issues in North America. Furthermore, the area has excellent research and healthcare infrastructure, which supports the creation and uptake of personalized medicine strategies. Furthermore, strong investments in healthcare innovation and regulations and initiatives from the government encourage the expansion of the personalized psychiatry market in North America. The personalized psychiatry market is anticipated to grow at the quickest rate in the Asia-Pacific area. This rise is driven by elements including expanding investments in healthcare technology, raising awareness of mental health issues, and developing healthcare infrastructure.

Personalized Psychiatry Market- Competitive Landscape:

Major pharmaceutical companies are increasingly investing in personalized psychiatry. They are developing tailored medications based on genetic and biomarker information. Companies like Johnson & Johnson, Pfizer, and Roche are prominent in this space. Biotechnology companies are at the forefront of developing innovative diagnostic tools and therapies. They often focus on niche areas and leverage cutting-edge technologies. Examples include Myriad Genetics, Genomind, and Assurex Health. There is a growing trend of collaborations between pharmaceutical companies, biotech firms, academic institutions, and technology providers. These partnerships are essential for advancing research and bringing new personalized therapies to market. For instance, in May 2024, Osmind, the foremost psychiatric handling and investigate platform, publicized a ground-breaking partnership with the American Psychiatric Association (APA) to advance the implementation of measurement-based care (MBC) as well as precision dealing in psychiatry.

Recent Developments:

In August 2021, MindMed announced a collaboration with Florian to advance the development of personalized psychiatry for anxiety disorders. Florian has deep domain experience in RWE and outcomes studies and has developed a variety of information products to serve the healthcare industry.

In May 2024, UAB expanded access to mental health services through advanced practice provider collaborations. They are playing a critical role in meeting the community's overwhelming need for professional, competent, and uniquely compassionate mental health services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED PSYCHIATRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GreyBird Ventures

Sunovion Pharmaceuticals Inc.

HMNC Holding GmbH

Arcara Personalized Psychiatry

Starling Minds

Karuna Therapeutics

CBT Plus

AltheaDx, Inc.

WayForward

BrightQuest

Peak Mental Wellness

Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Genomics
  • Digital Therapeutics
  • Software

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY THERAPEUTIC AREAS - MARKET ANALYSIS, 2019 - 2032

  • Depression and Anxiety
  • Bipolar Disorders
  • Addiction
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

  • Mental Health Professionals
  • Patients
  • Healthcare Providers

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Sequencing
  • Polymerase Chain Reaction
  • Microarray
  • Immunoassay
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Personalized Psychiatry Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Personalized Psychiatry Market Snippet by Product Type
    • 2.1.2.Personalized Psychiatry Market Snippet by Therapeutic Areas
    • 2.1.3.Personalized Psychiatry Market Snippet by End User
    • 2.1.4.Personalized Psychiatry Market Snippet by Technology
    • 2.1.5.Personalized Psychiatry Market Snippet by Country
    • 2.1.6.Personalized Psychiatry Market Snippet by Region
  • 2.2.Competitive Insights

3.Personalized Psychiatry Key Market Trends

  • 3.1.Personalized Psychiatry Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Personalized Psychiatry Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Personalized Psychiatry Market Opportunities
  • 3.4.Personalized Psychiatry Market Future Trends

4.Personalized Psychiatry Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Personalized Psychiatry Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Personalized Psychiatry Market Landscape

  • 6.1.Personalized Psychiatry Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Personalized Psychiatry Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Genomics
    • 7.1.3.Digital Therapeutics
    • 7.1.4.Software

8.Personalized Psychiatry Market - By Therapeutic Areas

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Therapeutic Areas, 2023 & 2032 (%)
    • 8.1.2.Depression and Anxiety
    • 8.1.3.Bipolar Disorders
    • 8.1.4.Addiction
    • 8.1.5.Others

9.Personalized Psychiatry Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Mental Health Professionals
    • 9.1.3.Patients
    • 9.1.4.Healthcare Providers

10.Personalized Psychiatry Market - By Technology

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 10.1.2.Sequencing
    • 10.1.3.Polymerase Chain Reaction
    • 10.1.4.Microarray
    • 10.1.5.Immunoassay
    • 10.1.6.Others

11.Personalized Psychiatry Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Personalized Psychiatry Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Personalized Psychiatry Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Personalized Psychiatry Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Personalized Psychiatry Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Personalized Psychiatry Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Personalized Psychiatry Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GreyBird Ventures
    • 12.2.2.Sunovion Pharmaceuticals Inc.
    • 12.2.3.HMNC Holding GmbH
    • 12.2.4.Arcara Personalized Psychiatry
    • 12.2.5.Starling Minds
    • 12.2.6.Karuna Therapeutics
    • 12.2.7.CBT Plus
    • 12.2.8.AltheaDx, Inc.
    • 12.2.9.WayForward
    • 12.2.10.BrightQuest
    • 12.2.11.Peak Mental Wellness
    • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us